The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study
Open accessAbstract
OBJECTIVE: To study whether the risk of amyotrophic lateral sclerosis (ALS) is increased in people with prior autoimmune disease. METHODS: An all-England hospital record-linkage dataset spanning 1999-2011 was used. Cohorts were constructed of people with each of a range of autoimmune diseases; the incidence of ALS in each disease cohort was compared with the incidence of ALS in a cohort of individuals without prior admission for the autoimmune disease. RESULTS: There were significantly more cases than expected of ALS associated with a prior diagnosis of asthma, celiac disease, younger-onset diabetes (younger than 30 years), multiple sclerosis, myasthenia gravis, myxedema, polymyositis, Sjögren syndrome, systemic lupus erythematosus, and ulcerative colitis. CONCLUSIONS: Autoimmune disease associations with ALS raise the possibility of shared genetic or environmental risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Considering that diabetes mellitus type 1 has been shown to have a positive association with the risk of ALS, we expect that the misclassification of some cases of diabetes mellitus type 1 as type 2 would most likely have underestimated the real inverse association between diabetes type 2 and risk of ALS [38, 41].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Considering that diabetes mellitus type 1 has been shown to have a positive association with the risk of ALS, we expect that the misclassification of some cases of diabetes mellitus type 1 as type 2 would most likely have underestimated the real inverse association between diabetes type 2 and risk of ALS [38, 41].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, patients with autoimmune diseases showed a slightly increased frequency of developing ALS.86”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Self-citationHaverkamp, L. J., Appel, V., & Appel, S. H. (1995) · Brain · doi:10.1093/brain/118.3.707 · Cited by 697
Energy metabolism in amyotrophic lateral sclerosis
Dupuis, L., Pradat, P., Ludolph, A. C., & Loeffler, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70224-6 · Cited by 575
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Chio, A. (2005) · Brain · doi:10.1093/brain/awh373 · Cited by 484
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
Philips, T., Bento‐Abreu, A., Nonneman, A., Haeck, W., Staats, K. A., Geelen, V., Hersmus, N., Küsters, B., Bosch, L. V. D., Damme, P. V., et al. (2013) · Brain · doi:10.1093/brain/aws339 · Cited by 282
Premorbid weight, body mass, and varsity athletics in ALS
Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002) · Neurology · doi:10.1212/wnl.59.5.773 · Cited by 246
Seminog, O. O., & Goldacre, M. J. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202480 · Cited by 182
Self-citationTDP-43 frontotemporal lobar degeneration and autoimmune disease
Miller, Z. A., Rankin, K. P., Graff-Radford, N. R., Takada, L. T., Sturm, V. E., Cleveland, C. M., Criswell, L. A., Jaeger, P. A., Stan, T., Heggeli, K. A., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304644 · Cited by 170
Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis
Gallo, V., Wark, P. A., Jenab, M., Pearce, N. E., Brayne, C., Vermeulen, R. C. H., Andersen, P. M., Hallmans, G., Kyrozis, A., Vanacore, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840689 · Cited by 167
Lifetime physical activity and the risk of amyotrophic lateral sclerosis
Huisman, M. H. B., Seelen, M., de Jong, S. W., Dorresteijn, K. R. I. S., van Doormaal, P. T. C., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., van den Berg, L. H., & Veldink, J. H. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304724 · Cited by 156
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Risk factors for amyotrophic lateral sclerosis
Fang, F., Ingre, C., Roos, P. M., Kamel, F., & Piehl, F. (2015) · Clinical Epidemiology · doi:10.2147/clep.s37505 · Cited by 503
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja‐Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 318
Metadata
- Authors
- Turner, M. R., Goldacre, R., Ramagopalan, S., Talbot, K., & Goldacre, M. J.
- Affiliations
- John Radcliffe Hospital (GB)
- Venue
- Neurology
- Published
- 2013-10
- Volume
- 81
- Issue
- 14
- Pages
- 1222-1225
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3795611
- OpenAlex
- W2167295920
- Cited by
- 185
- References
- 28
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 12 · 2023: 13 · 2022: 22 · 2021: 19 · 2020: 19 · 2019: 8 · 2018: 12 · 2017: 13 · 2016: 18 · 2015: 20 · 2014: 11 · 2013: 2
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Motor Neurone Disease Association (TURNER/JAN13/944-795)
- Medical Research Council (MR/K01014X/1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- amyotrophic lateral sclerosis, autoimmune disease, asthma, celiac disease, multiple sclerosis, myasthenia gravis, myxedema, polymyositis, Sjögren's syndrome, systemic lupus erythematosus, ulcerative colitis, type 1 diabetes, ALS incidence, genetic risk factors, environmental risk factors
- MeSH terms
- Amyotrophic Lateral Sclerosis, Autoimmune Diseases, England, Female, Hospital Records, Humans, Male, Risk, Cohort Studies, Comorbidity, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
